In an age when evidence-based care is increasingly important, how trustworthy are current clinical practice guidelines?
not rated yet |
0
A 2012 law that loosened conflict-of-interest restrictions for FDA advisory panels could weaken the agency's review system and could allow more drugs with safety problems to gain market approval, says a new analysis published ...
1 / 5 (1) |
4
|
(AP)—Former Navy Secretary Richard J. Danzig, who has served as a bio-warfare adviser to the president, the Pentagon, and the Department of Homeland Security, urged the government to stockpile an anti-anthrax drug while ...
5 / 5 (1) |
0
